Estudo randomizado | S-1 com oxaliplatina é não inferior a fluorouracil, leucovorina com oxaliplatina como quimioterapia perioperatória para câncer gástrico ressecável e localmente avançado.

Effect of S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Plus Oxaliplatin as Perioperative Chemotherapy for Locally Advanced, Resectable Gastric Cancer: A Randomized Clinical Trial – JAMA Network Open

Comentário no Twitter

In this RCT, S-1 plus oxaliplatin was noninferior to fluorouracil, leucovorin plus oxaliplatin as perioperative chemotherapy regimen for patients with locally advanced gastric cancer. https://t.co/W6fc1YcSBd

— JAMA Network Open (@JAMANetworkOpen) February 28, 2022